A single copy of this article may be reprinted for personal, noncommercial use only.
CA 125 testBy Mayo Clinic staff
Original Article: http://www.mayoclinic.com/health/ca-125-test/MY00590
A CA 125 test measures the amount of the protein CA 125 (cancer antigen 125) in your blood.
Many different conditions can cause an increase in CA 125. These include uterine fibroids, endometriosis, pelvic inflammatory disease and cirrhosis, as well as pregnancy and normal menstruation. Certain cancers, including ovarian, endometrial, peritoneal and fallopian tube, also can cause CA 125 to be released into the bloodstream.
A CA 125 test isn't accurate enough to use for cancer screening in all women — especially premenopausal women — because many benign conditions can increase the CA 125 level. What's more, CA 125 levels are normal in many women with early-stage ovarian cancer.
Why it's done
You may have a CA 125 test for several reasons:
- To monitor cancer treatment. If you've been diagnosed with ovarian, endometrial, peritoneal or fallopian tube cancer, your doctor may recommend a CA 125 test on a regular basis to monitor your condition and treatment. But such monitoring hasn't been shown to improve the outcome for women with ovarian cancer, and it might lead to additional and unnecessary rounds of chemotherapy or other treatments.
- To screen for ovarian cancer if you're at high risk. If you've been identified as being at high risk of developing ovarian cancer due to a very strong family history of the disease or because you have the BRCA1 or BRCA2 gene mutation, your doctor may recommend a CA 125 test as one way to screen for the disease. There is no evidence that screening women with CA 125 decreases the chance of dying from ovarian cancer. An elevated level of CA 125 could prompt your doctor to put you through unnecessary and possibly harmful tests, so carefully discuss with your doctor the risks and benefits of having this test.
- To check for cancer recurrence. Rising CA 125 levels may indicate that ovarian cancer has come back after treatment. Again, however, regular monitoring of CA 125 has not been shown to improve outcomes for women with ovarian cancer and may lead to additional and unnecessary rounds of chemotherapy or other treatments.
Your doctor may suggest a CA 125 test it's suspected that you have ovarian, endometrial, peritoneal or fallopian tube cancer. However, a CA 125 test cannot diagnose these diseases. Only a biopsy of tissue can confirm a diagnosis of these cancers. Other tests that may be helpful in evaluating these cancers include a transvaginal or pelvic ultrasound and computerized tomography (CT).
How you prepare
If your blood is being tested only for CA 125, you can eat and drink normally before the test.
What you can expect
For a CA 125 test, a member of your health care team takes a sample of blood by inserting a needle into a vein in your arm. The blood sample is sent to a lab for analysis. You can return to your usual activities immediately.
Results of the CA 125 test are measured in units per milliliter (U/mL). The normal range for CA 125 is less than 35 U/mL.
If your CA 125 level is higher than normal, your doctor will likely repeat the test. You may have a benign condition, or the test result could mean that you have ovarian, endometrial, peritoneal or fallopian tube cancer. But CA 125 is not a definitive diagnostic test for cancer, so your doctor will evaluate the results along with those of other tests that may be ordered.
If you've been previously diagnosed with ovarian, endometrial, peritoneal or fallopian tube cancer, a decreasing CA 125 level often indicates that the cancer is responding to treatment. A rising CA 125 level may indicate a return or continued growth of the cancer.
For specific information about what your CA 125 test results mean, talk with your doctor.
- CA-125. Lab Tests Online. http://labtestsonline.org/understanding/analytes/ca125/. Accessed March 2, 2011.
- Carlson KJ. Screening for ovarian cancer. http://www.uptodate.com/home/index.html. Accessed March 2, 2011.
- Clarke-Pearson DL. Screening for ovarian cancer. New England Journal of Medicine. 2009;361:170.
- Understanding CA 125 levels: A guide for ovarian cancer patients. Gynecologic Cancer Foundation. http://www.wcn.org/downloads/CA125levels.pdf. Accessed March 2, 2011.
- Tumor markers: Questions and answers. National Cancer Institute. http://www.cancer.gov/cancertopics/factsheet/detection/tumor-markers. Accessed March 2, 2011.
- How is endometrial cancer diagnosed? American Cancer Society. http://www.cancer.org/Cancer/EndometrialCancer/DetailedGuide/endometrial-uterine-cancer-diagnosis. Accessed March 2, 2011.
- Stany MP, et al. Clinical decision making using ovarian cancer risk assessment. AJR. 2010;194:337.
- Memarzadeh S, et al. Cancer of the fallopian tube. http://www.uptodate.com/home/index.html. Accessed March 2, 2011.
- Goff B. Early detection of epithelial ovarian cancer: Role of symptom recognition. http://www.uptodate.com/home/index.html. Accessed March 2, 2011.
- Rustin GJS, et al. Early versus delayed treatment of relapsed ovarian cancer (MRC OV05/EORTC 55955): A randomised trial. The Lancet. 2010;376:1155.
- Ovarian cancer: Can ovarian cancer be found early? American Cancer Society. http://www.cancer.org/Cancer/OvarianCancer/DetailedGuide/ovarian-cancer-detection. Accessed March 2, 2011.
- Ovarian cancer: Common questions about symptoms and screening. American Cancer Society. http://www.cancer.org/Cancer/news/ovarian-cancer-why-screening-isnt-routine?ssDomain. Accessed March 2, 2011.
- Laboratory reference values. CA 125. Rochester, Minn.: Mayo Foundation for Medical Education and Research; Feb. 2011.
- Bast RC. CA 125 and the detection of recurrent ovarian cancer. Cancer. 2010;116:2850.